GPT HEALTHCARE IPO
73% IPOs trading above issue price as primary market shines in H1, four turn multibaggers
The fundraising of Rs 26,272 crore, however fell short of the previous two years likely due to the absence of mega issues. Investors' reception also remained positive with only one failed IPO.
Go Digit IPO opens; quick commerce boost for FMCG firms
Go Digit General Insurance launched its Rs 2,615 crore initial public offering (IPO) on Wednesday. More details on this in today's ETtech Top 5.
New AI law to protect Indian publishers; Navi eyes $2 billion valuation
News publishers in India have been seeking changes to the information technology rules to ensure fair compensation for the use of their content by generative AI models. The Digital News Publishers Association (DNPA) grouping has sent a letter and made representations to the ministries of electronics and information technology, and information and broadcasting, seeking protection from likely copyright violations by AI models, ET reported in January.
Regulatory actions prompt rethink among fintechs; and other top startup stories this week
Fintech industry faces regulatory challenges, affecting players like Paytm Payments Bank. Market dynamics shift with increasing regulatory scrutiny. Fintech startups adapt to changing landscape and consumer-focused regulations, emphasizing compliance and strategic recalibration.
GPT Healthcare debut exceeds expectations. Should you wait for more upside?
The shares of GPT Healthcare debuted with a 15% premium over the issue price on Thursday, which was slightly above expectations. Most analysts priced in a 9-10% premium listing.
Paytm shares extend losses, fall 10% in three sessions
Paytm Share Price: Vijay Shekhar Sharma's resignation as the part-time non-executive chairman and board member at Paytm Payments Bank did not cut much ice with the investors who preferred to sell shares in hordes. Around 10 am, nearly 42.78 lakh shares were trading on the NSE.
- Go To Page 1
GPT Healthcare shares list at 16% premium over IPO price
GPT Healthcare Share Price: GPT Healthcare's IPO debuted with a 16.2% premium. It raised Rs 525 crore for prepayment/repayment of borrowings. The company operates four multispecialty hospitals. Revenue grew at 53.87% CAGR. Three-month total income was Rs 97.63 crore, net profit was Rs 9.98 crore.
GPT Healthcare to debut tomorrow. Here's what GMP indicates ahead of listing
The shares of GPT Healthcare will debut on the exchanges on Thursday. Ahead of the listing, the company's shares are trading with a premium of Rs 17 in the unlisted market.
GPT Healthcare IPO allotment: Check status, listing date, GMP and other details
GPT Healthcare IPO received 8.5 times subscription. Share allotment to be finalized. Check status on BSE or registrar website. Shares trading with Rs 10 premium. Proceeds used for repayment. Competing with listed peers. JM Financial is the sole book running lead manager.
GPT Healthcare IPO fully subscribed on last day. Check GMP and other details
In the unlisted market, the company's shares are trading with a premium of Rs 10, marginally up from the previous week.
Global cues, FII flows, F&O expiry among 8 factors to drive Dalal Street this week
Benchmark indices gained close to 1% last week, reaching lifetime highs, driven by foreign investor inflows. Volatility is expected due to the expiry of the February derivative series. Nifty may reach 22400 and possibly 22700. Macro data and global markets will be monitored. Auto sales and IPOs are also noteworthy.
IPO calendar: 6 new issues, 5 listings to keep primary market busy next week
In the week gone by, two mainboard IPOs Juniper Hotels and GPT Healthcare opened with a target to raise Rs 2,325 crore.
GPT Healthcare IPO: Check subscription on Day 2, GMP and other details
The proceeds from the fresh issue will be used for prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company besides general corporate purposes.
GPT Healthcare IPO: Check subscription on Day 1, GMP and other details
GPT Healthcare IPO is priced at Rs 177-186 per share for its Rs 525-crore IPO. Investors can make bids for 80 shares in one lot and its multiples thereafter.
GPT Healthcare IPO opens for subscription. Should you apply?
GPT Healthcare IPO: GPT Healthcare's IPO, valued at Rs 525 crore, opened for subscription. The company raised Rs 157 crore from anchor investors. Analysts advise subscribing for fair valuations, comprehensive services, and quality medical practices. The price band is Rs 177-186 per share.
GPT Healthcare has promising prospects, but wait for listing to get clearer picture
Set up in 2000 as an eight-bed hospital at Salt Lake in Kolkata by laparoscopic surgeon Dr Om Tantia, the company now operates four secondary and tertiary care hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of 561 beds.
GPT Healthcare garners Rs 157 cr from anchor investors ahead of IPO
GPT Healthcare Ltd, which operates and manages mid-sized multi-specialty hospitals under the ILS Hospitals brand, on Wednesday collected Rs 157.54 crore from anchor investors a day before its Initial Public Offering (IPO).
GPT Healthcare IPO to open on Thursday. What GMP signals ahead of subscription?
GPT Healthcare has fixed a price band of Rs 177-186 per share for its Rs 525-crore IPO. The issue closes on February 26. Investors can make bids for 80 shares in one lot and multiples thereafter. The proceeds will be used for prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company and for general corporate purposes.
Thai Casting IPO booked 48 times on Day 3. Check GMP and other details
The IPO, which will close on February 20, is priced at Rs 77 at the upper end. About 50% of the offer is reserved for qualified institutional buyers, 35% for retail investors and the rest 15% for non-institutional investors.
GPT Healthcare sets price band of Rs 177-186 for its Rs 525-cr IPO
The IPO is a combination of a fresh issue of equity shares aggregating to Rs 40 crore and an Offer For Sale (OFS) of up to 2.6 crore equity shares by private equity firm BanyanTree Growth Capital II.
FII flows, IPO action among 9 factors that will steer D-Street this week
"The market closed near its peak, with the Bank Nifty index emerging as a standout performer. Despite a rocky start, the PSU index demonstrated resilience, bouncing back from early declines. With few definitive signals this week, the market focus remains on the trajectory of the dollar index and US bond yields," Santosh Meena, Head of Research, Swastika Investmart, said.
IPO calendar: 4 new issues, 7 listings to drive primary market activity next week
In the upcoming week, mainboard IPOs of Juniper Hotels and GPT Healthcare will hit the street to raise over Rs 2,000 crore. Meanwhile, SME companies Zenith Drugs and Dream Roll Tech are also scheduled to launch their issues.
Kolkata-based GPT Healthcare announces IPO dates. Check details
The IPO, with a face value of Rs 10, consists of a fresh issue of equity shares, aggregating to Rs 40 crore, and an offer for sale (OFS) of up to 2.6 crore equity shares by BanyanTree Growth Capital II, LLC, a Mauritius-based structured private equity.
GPT Healthcare's IPO to open on Feb 22; PE firm BanyanTree Growth Capital to exit
The IPO is a combination of a fresh issue of equity shares aggregating to Rs 40 crore, and an Offer For Sale (OFS) of up to 2.6 crore equity shares by private equity firm BanyanTree Growth Capital II.
Dunzo’s survival hinges on Reliance; Q&A with Instacart founder Apoorva Mehta
Reliance Retail, which is an investor in Dunzo, is yet to sign off on a much-needed capital infusion in the cash-strapped company. All about this and more, in today’s Morning Dispatch.
Kolkata-based GPT Healthcare refiles DRHP with Sebi for IPO
The offer is being made through the book-building process, wherein 50% will be available for allocation on a proportionate basis to qualified institutional buyers, 15% for non-institutional bidders, and 35% for retail investors.
Amazon’s sales from international ops remain flat; Growth worries for Snap, Pinterest
Amazon's net sales from international operations remained largely flat in the quarter ended March 2023. CEO Andy Jassy said in an earnings call that the negative margins in the international business had narrowed.
A Rs 12,000 crore IPO fest is coming to Dalal Street
After a few IPOs launched in May struggled to sail through, investors and companies turned cautious amid a weak secondary market. While there were no IPOs in June and July, only six companies have since made initial public share sales, raising about ₹3,500 crore.
GPT Healthcare gets Sebi approval for IPO
The IPO comprises fresh issuance of equity shares worth Rs 17.5 crore and an OFS of up to 2.98 crore equity shares by a promoter entity and an investor
Load More
